This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Comment: UK antitrust watchdog's vindication over trial tactics has lessons for all

By Simon Zekaria ( September 13, 2024, 14:30 GMT | Comment) -- Companies at risk of UK antitrust enforcement should be alert to appeal judges’ findings that the competition watchdog isn't required to argue or prove dishonesty by executives in cartel cases. A recent Court of Appeal ruling vindicated the Competition and Markets Authority's cross-examination of witnesses at a trial over drug companies’ behavior in the hydrocortisone market — and clarified the enforcer's autonomy to make its case in court.UK antitrust enforcers will have enjoyed reading a recent ruling by appeal judges that reinstated a high-profile infringement decision against Auden Mckenzie and other drugmakers that colluded over the supply of hydrocortisone....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections